Use of Tellurium Compounds for Protection from Ultra-Violet Radiation
AssigneeBioMAS Ltd.
InventorsBenjamin Sredni, Michael Albeck
Life of this patent
Estimating the term…
Abstract
Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a tellurium-containing compound. A pharmaceutical composition for treatment of skin conditions such as basal cell carcinoma an/or actinic keratosis is also provided.
Claims46
1-40. (canceled)
A method of protecting the skin of a subject against damage caused by ultraviolet radiation, wherein said ultraviolet radiation has a wavelength in the range of from about 280 to about 380 nanometers, the method comprising administering to the subject a therapeutically effective amount of at least one tellurium-containing compound.
A pharmaceutical composition identified for use in protection of the skin of a subject against damage caused by ultraviolet radiation, comprising at least one tellurium-containing compound and a pharmaceutically acceptable carrier, wherein said ultraviolet radiation has a wavelength in the range of from about 280 to about 380 nanometers.
A method of prevention or treatment of damage to the skin of a subject caused by ultraviolet radiation, wherein said ultraviolet radiation has a wavelength in the range of from about 280 to about 380 nanometers, the method comprising administering to the subject a therapeutically effective amount of at least one tellurium-containing compound.
A method of prevention of ultraviolet radiation-induced induction of IL-10 in the skin of a subject, wherein said ultraviolet radiation has a wavelength in the range of from about 280 to about 380 nanometers, the method comprising administering to the subject a therapeutically effective amount of at least one tellurium-containing compound.
A method of prevention of skin cancer caused by repetitive and/or frequent exposure to ultraviolet-radiation, wherein said ultraviolet-radiation has a wavelength in the range of from about 280 to about 380 nanometers, the method comprising administering to the skin of the subject a therapeutically effective amount of at least one tellurium-containing compound prior to exposure to said ultraviolet-radiation.
Dependencies are inferred from the claim text.